Induction of interleukin 10 by sublingual immunotherapy for house dust mites: A preliminary report

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 1, 2005, Pages 38-44

  Ciprandi, Giorgio ^a   Fenoglio, Daniela ^b   Cirillo, Ignazio ^c   Vizzaccaro, Andrea ^c   Ferrera, Alessandra ^b   Tosca, Maria Angela ^d   Puppo, Francesco ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c Ospedale Marina Militare   (Italy)

^d G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HOUSE DUST ALLERGEN; INTERLEUKIN 10; STALORAL 100 IR;

ADULT; ALLERGY; ARTICLE; ATOPY; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 22544467453     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61186-6     Document Type: Article

References (45)

1. Frew AJ. Immunotherapy of allergic disease. J Allergy Clin Immunol. 2003;111(2 suppl):S712-S719.
2. Bousquet J, Lockey RF, Mailing HJ. WHO position paper: allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy. 1998;53(suppl 44):1-42.
3. Akbari O, Stock P, DeKruiff RH, Umetsu DT. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol. 2003; 15:627-633.
4. Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol. 2003;3:1-8.
5. Umetsu DT, Akbari O, Dekruiff RH. Regulatory T cells control the development of allergic disease and asthma. J Allergy Clin Immunol. 2003;112:480-487.
6. Jutel M, Akdis M, Budak F, et al. IL10 and TGFbeta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003; 33:1205-1214.
7. Francis JN, Till SJ, Durham SR. Induction of IL1+CD4+CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 2003;111:1255-1261.
8. Sheik S, Zitt M, Bouboulis D, Pahwa S, Fried M. Modulation of cytokine production during immunotherapy in atopic asthmatics: a potential role for cytokine antagonists: a preliminary study. Pediatr Asthma Allergy Immunol. 1996;10: 161-168.
9. Frieri M. New frontiers in immunotherapy. Allergy Asthma Proc. 1999;20:281-288.
10. Savolainen J, Laaksonen K, Rantio-Lehtimaki A, Terho EO. Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy. Clin Exp Allergy. 2004;34:413-419.
11. Blaser K, Akdis CA Interleukin-10, T regulatory cells and specific allergy treatment. Clin Exp Allergy. 2004;34:328-331.
12. Ling EM, Smith T, Nguyen XD, et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet. 2004;363: 608-615.
13. Canonica GW, Passalacqua G. Noninjection routes for immunotherapy. J Allergy Clin Immunol. 2003;111:437-448.
14. Mailing HJ, Abreo-Nogueira J, Alvarez-Cuesta E, et al. Local immunotherapy [position paper]. Allergy. 1998;53:933-948.
15. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 suppl): S147-S334.
16. Passalacqua G, Lombardi C, Canonica GW. Sublingual immunotherapy: an update. Curr Opin Allergy Clin Immunol. 2004;4:31-36.
17. Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis [Cochrane review]. Cochrane Database Syst Rev. 2003;2:CD002893.
18. Giannarini L, Maggi E. Decrease of allergen-specific-T-cell response induced by local nasal immunotherapy. Clin Exp Allergy. 1998;28:404-412.
19. TePas EC, Hoyte EG, McIntire JJ, Umetsu DT. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. Ann Allergy Asthma Immunol. 2004;92: 25-31.
20. Bachert C, Van kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol. 1999;118:375-379.
21. Kon OM, Kay AB. T cells and chronic asthma. Int Arch Allergy Immunol 1999;118:133-135.
22. Tang C, Inman MD, van Rooijen N, et al. Th type-1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism. J Immunol. 2001;166:1471-1481.
23. Hansen G, Berry G, Dekruiff RH, Umetsu DT. Allergen specific Th1 cells fail to counterbalance Th2 cell-induced airway hyper-reactivity but cause severe airway inflammation. J Clin Invest. 1999;103:175-183.
24. Bach J. The effects of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347:911-920.
25. Jeannine P, Lecoanet S, Delneste Y, et al. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998;160:3555-3561.
26. Royer B, Varadaradjalou S, Saas P, et al. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy. 2001;31:694-704.
27. Takanasi S, Nonaka R, Xing Z, et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med. 1994;180: 711-715.
28. Schandene L, Alonso-Vega C, Willems F, et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol. 1994;152:4368-4374.
29. Groux H, Bigler M, de Vries JE, Roncarolo MG. Interleukin-10 induces a long term antigen-specific anergic state in human CD4+ T cells. J Exp Med. 1996;184:19-29.
30. Bullens DMA, Van den Keybus, Dilissen E, et al. Allergen-specific T cells from birch-pollen-allergic patients and healthy controls differ in T helper 2 cytokine and in IL-10 production. Clin Exp Allergy. 2004;34:879-887.
31. Arikan C, Bahceciler NN, Deniz G, et al. Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunological parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy. 2004; 34:398-405.
32. Ippoliti F, De Santis W, Volterrani A, et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol. 2003;14:216-221.
33. Fanta C, Bohle B, Hirt W, et al. Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy. Int Arch Allergy Immunol. 1999;120:218-224.
34. TePas EC, Hoyte EG, McIntire JJ, Umetsu DT. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. Ann Allergy Asthma Immunol. 2004;92: 1-2.
35. Mowart AM. The regulation of immune response to dietary proteins. Immunol Today. 1987;8:93-96.
36. Holt PG, Vines J, Britten D. Sublingual allergen administration, I: selective suppression of IgE production in rats with high allergen doses. Clin Allergy. 1988;18:229-234.
37. Chen Y, Kuchroo VK, Inobe J, et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune enkephalomyelitis. Science. 1994;265:1237-1240.
38. Montagnoli C, Bacci A, Bozza S, et al. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol. 2002;169:6298-6308.
39. Husby S, Mestecky J, Moldoveanu Z, et al. Oral tolerance in humans. J Immunol. 1994;152:4663-4670.
40. Weiner LW. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today. 1997;18:335-343.
41. Nouri-Aria KT, Wachholz PA, Francis JN, et al. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 2004;172: 3252-3259.
42. Hsu CH, Lin SS, Liu FL, Sulu C, Yeh SD. Oral administration of a mite allergen expressed by zucchini yellow mosaic virus in cucurbit species downregulates allergen-induced airway inflammation and IgE synthesis. J Am Coll Immunol. 2004;115: 1084-1090.
43. Till SJ, Frances JN, Aria, Kaplan, Nauri, Durham SR. Mechanism IT. J Am Coll Immunol. 2004;113:1025-1034.
44. Norman PS. Immunotherapy 1999-2004. J Am Coll Immunol. 2004;113:1013-1023.
45. Lima MT, Wilson D, Pitkin L, et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy. 2002;32:507-514.